Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3430878 Target Snapshot

Retinoic acid receptor RXR-alpha/oxysterols receptor LXR-beta · PROTEIN COMPLEX · Homo sapiens

Back to Search Search this target Browse approvals Evidence Card
68Compounds
7Assays
0Approved Drugs
70.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Research home Demo workspace
Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P19793. Use UniProt P19793 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P19793 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Retinoic acid receptor RXR-alpha/oxysterols receptor LXR-beta as ChEMBL target CHEMBL3430878, mapped to UniProt P19793. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Retinoic acid receptor RXR-alpha/oxysterols receptor LXR-beta
PROTEIN COMPLEX · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL3430878
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P19793
Retinoic acid receptor RXR-alpha
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Retinoic acid receptor RXR-alpha/oxysterols receptor LXR-beta is the right protein anchor across sources, using UniProt P19793 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

Preferred NameRetinoic acid receptor RXR-alpha/oxysterols receptor LXR-beta
Target TypePROTEIN COMPLEX
OrganismHomo sapiens
UniProtP19793
ChEMBL ↗ UniProt ↗ NCBI Protein ↗

Next Actions

SearchRun a focused querySearch the database using this target name as the starting context. ApprovalsCheck approved moleculesSee which approved drugs connect back to this target and its surrounding signal space. FeedScan papers & updatesStay in the project thread while checking recent papers and platform updates.
UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelRetinoic acid receptor RXR-alpha
UniProt AccessionP19793
Component TypeProtein
Sequence Length462 aa

Retinoic acid receptor RXR-alpha

Source · UniProt accession via ChEMBL component mapping
UniProt Context ↗
Review Cue

How to read this target

Review this target as Retinoic acid receptor RXR-alpha/oxysterols receptor LXR-beta, mapped to UniProt P19793. ChEMBL maps the protein component as Retinoic acid receptor RXR-alpha. Sequence length is 462 aa.

Mapped IDP19793
Review nameRetinoic acid receptor RXR-alpha/oxysterols receptor LXR-beta
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

3
Phase I
Assay Mix

Activity Type Distribution

KI44.0
EC5026.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4764328 10.8 EC50 0.016 Preclinical
CHEMBL4756418 10.46 EC50 0.035 Preclinical
CHEMBL4764838 10.28 EC50 0.052 Preclinical
CHEMBL4747448 10.17 EC50 0.067 Preclinical
CHEMBL4745005 10.08 EC50 0.083 Preclinical
CHEMBL4797369 10.06 EC50 0.088 Preclinical
CHEMBL4757761 10.04 EC50 0.092 Preclinical
CHEMBL4760781 10.02 EC50 0.095 Preclinical
CHEMBL4749385 9.99 EC50 0.103 Preclinical
CHEMBL62136 9.97 EC50 0.108 Preclinical
Distribution

pChEMBL Value Distribution

2
5.0
3
5.5
3
6.0
5
6.5
5
7.0
18
7.5
8
8.0
1
8.5
9
9.0
6
9.5
pChEMBL
Assay Landscape

Assay Landscape

7
Total Assays
66
Tested Compounds
1
Assay Types
Binding — 7 assays, 66 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 4 55 8.5
protein complex format 3 11 6.3

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine